Volume 11, Issue 2
Article

Meta‐analysis for 2 × 2 tables: A bayesian approach

John B. Carlin

Clinical Epidemiology and Biostatistics Unit, Royal Children's Hospital, Flemington Road, Parkville, Vic 3052, Australia

Search for more papers by this author
First published: 1992
Citations: 101

Abstract

This paper develops and implements a fully Bayesian approach to meta‐analysis, in which uncertainty about effects in distinct but comparable studies is represented by an exchangeable prior distribution. Specifically, hierarchical normal models are used, along with a parametrization that allows a unified approach to deal easily with both clinical trial and case‐control study data. Monte Carlo methods are used to obtain posterior distributions for parameters of interest, integrating out the unknown parameters of the exchangeable prior or ‘random effects’ distribution. The approach is illustrated with two examples, the first involving a data set on the effect of beta‐blockers after myocardial infarction, and the second based on a classic data set comprising 14 case‐control studies on the effects of smoking on lung cancer. In both examples, rather different conclusions from those previously published are obtained. In particular, it is claimed that widely used methods for meta‐analysis, which involve complete pooling of ‘O‐E’ values, lead to understatement of uncertainty in the estimation of overall or typical effect size.

Number of times cited according to CrossRef: 101

  • A Bayesian approach to assessing small‐study effects in meta‐analysis of a binary outcome with controlled false positive rate, Research Synthesis Methods, 10.1002/jrsm.1415, 11, 4, (535-552), (2020).
  • Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases, Medicine, 10.1097/MD.0000000000019695, 99, 16, (e19695), (2020).
  • Predictive value of indicators for identifying child maltreatment and intimate partner violence in coded electronic health records: a systematic review and meta-analysis, Archives of Disease in Childhood, 10.1136/archdischild-2020-319027, (archdischild-2020-319027), (2020).
  • The Use of Metaanalysis in Pharmacoepidemiology, Pharmacoepidemiology, 10.1002/9781119413431, (897-947), (2019).
  • Ex-situ priors: A Bayesian hierarchical framework for defining informative prior distributions in hydrogeology, Advances in Water Resources, 10.1016/j.advwatres.2019.02.003, (2019).
  • Meta analysis of binary data with excessive zeros in two-arm trials, Journal of Statistical Distributions and Applications, 10.1186/s40488-019-0099-x, 6, 1, (2019).
  • Use of a random effects meta‐analysis in the design and analysis of a new clinical trial, Statistics in Medicine, 10.1002/sim.7948, 37, 30, (4665-4679), (2018).
  • Bayesian Equivalence Testing and Meta-Analysis in Two-Arm Trials with Binary Data, Computational and Mathematical Methods in Medicine, 10.1155/2018/8134132, 2018, (1-8), (2018).
  • Bayesian Approaches to Randomized Trials, Journal of the Royal Statistical Society: Series A (Statistics in Society), 10.2307/2983527, 157, 3, (357-387), (2018).
  • Bayesian meta-analysis of correlation coefficients through power prior, Communications in Statistics - Theory and Methods, 10.1080/03610926.2017.1288251, 46, 24, (11988-12007), (2017).
  • Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta‐regression, Catheterization and Cardiovascular Interventions, 10.1002/ccd.26652, 89, 3, (351-366), (2016).
  • Bayesian network meta‐analysis for cluster randomized trials with binary outcomes, Research Synthesis Methods, 10.1002/jrsm.1210, 8, 2, (236-250), (2016).
  • Statistical Issues in Bayesian Meta-Analysis, Topics on Methodological and Applied Statistical Inference, 10.1007/978-3-319-44093-4, (155-172), (2016).
  • Reproducibility from the Perspective of Meta‐Analysis, Reproducibility, 10.1002/9781118865064, (141-167), (2016).
  • Bayesian Estimation and Testing in Random Effects Meta-Analysis of Rare Binary Adverse Events, Statistics in Biopharmaceutical Research, 10.1080/19466315.2015.1096823, 8, 1, (49-59), (2016).
  • Medical Decision Making with Incomplete Evidence—Choosing a Platelet Glycoprotein IIbIIIa Receptor Inhibitor for Percutaneous Coronary Interventions, Medical Decision Making, 10.1177/0272989X05275156, 25, 2, (222-228), (2016).
  • Multilevel models for meta-analysis, and their application to absolute risk differences, Statistical Methods in Medical Research, 10.1177/096228020101000602, 10, 6, (375-392), (2016).
  • Using Bayesian Inference to Perform Meta-Analysis, Evaluation & the Health Professions, 10.1177/01632780122034867, 24, 2, (165-189), (2016).
  • Bayesian methods in meta-analysis and evidence synthesis, Statistical Methods in Medical Research, 10.1177/096228020101000404, 10, 4, (277-303), (2016).
  • Evaluating Data from Closely Related Clinical Trials, Drug Information Journal, 10.1177/009286150103500428, 35, 4, (1317-1326), (2016).
  • Bayesian Approaches to Meta-analysi of ROC Curves, Medical Decision Making, 10.1177/0272989X9901900304, 19, 3, (252-264), (2016).
  • A Decision Analysis for an end of Phase II Go/Stop Decision, Drug Information Journal, 10.1177/009286159903300323, 33, 3, (821-833), (2016).
  • A Bayesian Approach to a General Regression Model for ROC Curves, Medical Decision Making, 10.1177/0272989X9801800412, 18, 4, (436-443), (2016).
  • Combining Event Rates from Clinical Trials: Comparison of Bayesian and Classical Methods, Annals of Pharmacotherapy, 10.1177/106002809603000504, 30, 5, (460-465), (2016).
  • Robustness considerations in Bayesian analysis, Statistical Methods in Medical Research, 10.1177/096228029600500403, 5, 4, (357-373), (2016).
  • Empirical Bayes Combination of Estimated Areas under ROC Curves Using Estimating Equations, Medical Decision Making, 10.1177/0272989X9601600109, 16, 1, (24-28), (2016).
  • An Application of the Beta-Binomial Model to Combine and Monitor Medical Event Rates in Clinical Trials, Drug Information Journal, 10.1177/009286159302700242, 27, 2, (515-523), (2016).
  • Controversies in meta-analysis: the case of the trials of serum cholesterol reduction, Statistical Methods in Medical Research, 10.1177/096228029300200205, 2, 2, (173-192), (2016).
  • Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data, The Journal of Pain, 10.1016/j.jpain.2015.07.009, 16, 12, (1221-1232), (2015).
  • Objective Bayesian meta‐analysis for sparse discrete data, Statistics in Medicine, 10.1002/sim.6163, 33, 21, (3676-3692), (2014).
  • Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis, Pharmaceutical Statistics, 10.1002/pst.1592, 13, 1, (55-70), (2013).
  • Evidence Synthesis for Decision Making 1, Medical Decision Making, 10.1177/0272989X13487604, 33, 5, (597-606), (2013).
  • Statin Use and Fracture Risk, Epidemiology, 10.1097/EDE.0b013e31829eef0a, 24, 5, (743-752), (2013).
  • Bayesian Inference for Logistic Models Using Pólya–Gamma Latent Variables, Journal of the American Statistical Association, 10.1080/01621459.2013.829001, 108, 504, (1339-1349), (2013).
  • Meta-analysis using Dirichlet process, Statistical Methods in Medical Research, 10.1177/0962280212453891, 25, 1, (352-365), (2012).
  • Evidence Synthesis for Decision Making 2, Medical Decision Making, 10.1177/0272989X12458724, 33, 5, (607-617), (2012).
  • The Use of Meta‐analysis in Pharmacoepidemiology, Pharmacoepidemiology, 10.1002/9781119959946, (723-756), (2012).
  • Bayesian Methods and WinBUGS, Evidence Synthesis for Decision Making in Healthcare, 10.1002/9781119942986, (17-42), (2012).
  • Bayesian Methods in Meta-Analysis, Encyclopedia of Biopharmaceutical Statistics, Third Edition, 10.1201/b14674, (116-121), (2012).
  • Comparison of transradial and femoral approaches for percutaneous coronary interventions: A systematic review and hierarchical Bayesian meta-analysis, American Heart Journal, 10.1016/j.ahj.2012.01.015, 163, 4, (632-648), (2012).
  • Bayesian meta-analysis of the effect of fasting, transport and lairage times on four attributes of pork meat quality, Meat Science, 10.1016/j.meatsci.2011.09.021, 90, 3, (584-598), (2012).
  • Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event, BMC Medical Research Methodology, 10.1186/1471-2288-12-64, 12, 1, (2012).
  • Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs, Journal of the American Statistical Association, 10.1080/01621459.1994.10476893, 89, 428, (1528-1534), (2012).
  • How can we improve the interpretation of systematic reviews?, BMC Medicine, 10.1186/1741-7015-9-31, 9, 1, (2011).
  • Overview, Strengths, and Limitations of Systematic Reviews and Meta-Analyses, Evidence-Based Practice: Toward Optimizing Clinical Outcomes, 10.1007/978-3-642-05025-1, (17-33), (2010).
  • Graphical displays for meta‐analysis: An overview with suggestions for practice, Research Synthesis Methods, 10.1002/jrsm.6, 1, 1, (66-80), (2010).
  • Meta-analysis of the effect of the halothane gene on 6 variables of pig meat quality and on carcass leanness1, Journal of Animal Science, 10.2527/jas.2009-2508, 88, 9, (2841-2855), (2010).
  • Bayesian Methods in Meta-Analysis, Encyclopedia of Biopharmaceutical Statistics, 10.3109/9781439822463, (116-121), (2010).
  • Multivariate Meta-Analysis, Encyclopedia of Biopharmaceutical Statistics, 10.3109/9781439822463, (897-903), (2010).
  • Development of a Bayesian Framework for Determining Uncertainty in Receiver Operating Characteristic Curve Estimates, IEEE Transactions on Knowledge and Data Engineering, 10.1109/TKDE.2009.50, 22, 1, (31-45), (2010).
  • References, Applied Bayesian Hierarchical Methods, 10.1201/9781584887218, (495-500), (2010).
  • Bayesian Approach to Multicentre Sparse Data, Communications in Statistics - Simulation and Computation, 10.1080/03610910701884062, 37, 4, (687-696), (2008).
  • Principles of and Procedures for Systematic Reviews, Systematic Reviews in Health Care, 10.1002/9780470693926, (23-42), (2008).
  • A Hierarchical Semiparametric Regression Model for Combining HIV‐1 Phylogenetic Analyses Using Iterative Reweighting Algorithms, Biometrics, 10.1111/j.1541-0420.2007.00753.x, 63, 3, (733-741), (2007).
  • Meta-analysis of clinical trials: a consumer's guide, Journal of Biopharmaceutical Statistics, 10.1080/10543409608835151, 6, 4, (377-394), (2007).
  • Bayesian approaches to random‐effects meta‐analysis: A comparative study, Statistics in Medicine, 10.1002/sim.4780142408, 14, 24, (2685-2699), (2007).
  • Prediction and decision making using Bayesian hierarchical models, Statistics in Medicine, 10.1002/sim.4780142002, 14, 20, (2173-2190), (2007).
  • Meta‐analysis: Weighing the evidence, Statistics in Medicine, 10.1002/sim.4780140206, 14, 2, (137-149), (2007).
  • Bayesian statistics in medicine: a 25 year review, Statistics in Medicine, 10.1002/sim.2672, 25, 21, (3589-3631), (2006).
  • BAYESIAN COMPUTATIONAL TOOLS: A BRIEF TUTORIAL, IFAC Proceedings Volumes, 10.3182/20060329-3-AU-2901.00004, 39, 1, (33-45), (2006).
  • The application of REML in clinical trials, Statistics in Medicine, 10.1002/sim.4780131602, 13, 16, (1601-1617), (2006).
  • Bayesian analysis of binary data from an audit of cervical smears, Statistics in Medicine, 10.1002/sim.4780122304, 12, 23, (2179-2189), (2006).
  • Analysis of incidence rates in cluster‐randomized trials of interventions against recurrent infections, with an application to trachoma, Statistics in Medicine, 10.1002/sim.2138, 24, 17, (2637-2647), (2005).
  • Intrinsic meta‐analysis of contingency tables, Statistics in Medicine, 10.1002/sim.2038, 24, 4, (583-604), (2005).
  • Methods for incorporating covariate adjustment, subgroup analysis and between‐centre differences into cost‐effectiveness evaluations, Health Economics, 10.1002/hec.1008, 14, 12, (1217-1229), (2005).
  • Synthesizing medical evidence: systematic reviews and metaanalyses, Neurosurgical Focus, 10.3171/foc.2005.19.4.6, 19, 4, (1-21), (2005).
  • Avian biodiversity monitoring in Australian rangelands, Austral Ecology, 10.1111/j.1442-9993.2004.01352.x, 29, 1, (93-99), (2004).
  • Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2003.12.019, 57, 9, (925-932), (2004).
  • A Hierarchical Bayesian Model for Combining Multiple 2 × 2 Tables Using Conditional Likelihoods, Biometrics, 10.1111/j.0006-341X.1999.00268.x, 55, 1, (268-272), (2004).
  • Multivariate meta‐analysis, Statistics in Medicine, 10.1002/sim.1410, 22, 14, (2309-2333), (2003).
  • Meta‐analysis: the glass eye of evidence‐based practice?, Nursing Inquiry, 10.1046/j.1440-1800.2002.00129.x, 9, 1, (24-30), (2002).
  • The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta‐regression analysis, European Journal of Heart Failure, 10.1016/S1388-9842(02)00041-7, 4, 4, (515-529), (2002).
  • Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales, Statistics in Medicine, 10.1002/sim.1189, 21, 11, (1601-1623), (2002).
  • Hierarchical Bayes Analysis of Smoking and Lung Cancer Data, Communications for Statistical Applications and Methods, 10.5351/CKSS.2002.9.1.115, 9, 1, (115-128), (2002).
  • Meta‐analysis of continuous outcome data from individual patients, Statistics in Medicine, 10.1002/sim.918, 20, 15, (2219-2241), (2001).
  • Two‐stage methods for the analysis of pooled data, Statistics in Medicine, 10.1002/sim.852, 20, 14, (2115-2130), (2001).
  • Bayesian Communication: A Clinically Significant Paradigm for Electronic Publication, Journal of the American Medical Informatics Association, 10.1136/jamia.2000.0070254, 7, 3, (254-266), (2000).
  • Bayesian hierarchical models, Numerical Computer Methods, Part C, 10.1016/S0076-6879(00)21200-7, (305-330), (2000).
  • A multilevel model framework for meta‐analysis of clinical trials with binary outcomes, Statistics in Medicine, 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L, 19, 24, (3417-3432), (2000).
  • Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening, Statistics in Medicine, 10.1002/1097-0258(20001230)19:24<3359::AID-SIM710>3.0.CO;2-N, 19, 24, (3359-3376), (2000).
  • Strategies for comparing treatments on a binary response with multi‐centre data, Statistics in Medicine, 10.1002/(SICI)1097-0258(20000430)19:8<1115::AID-SIM408>3.0.CO;2-X, 19, 8, (1115-1139), (2000).
  • Tutorial in Biostatistics. Meta‐analysis: formulating, evaluating, combining, and reporting by S‐L. T. Normand, Statistics in Medicine, 18, 321–359 (1999), Statistics in Medicine, 10.1002/(SICI)1097-0258(20000315)19:5<753::AID-SIM427>3.0.CO;2-F, 19, 5, (753-759), (2000).
  • Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs, Journal of the American Statistical Association, 10.1080/01621459.1999.10473815, 94, 445, (16-28), (1999).
  • Generalized linear mixed models for meta‐analysis, Statistics in Medicine, 10.1002/(SICI)1097-0258(19990330)18:6<643::AID-SIM76>3.0.CO;2-M, 18, 6, (643-654), (1999).
  • The association between vasectomy and prostate cancer: a systematic review of the literature, Fertility and Sterility, 10.1016/S0015-0282(98)00142-3, 70, 2, (191-200), (1998).
  • Controlled trials investigating the use of one partially hydrolyzed whey formula for dietary prevention of atopic manifestations until 60 months of age: An overview using meta-analytical techniques, Nutrition Research, 10.1016/S0271-5317(98)00120-1, 18, 8, (1425-1442), (1998).
  • Understanding and testing for heterogeneity across 2×2 tables: application to meta‐analysis, Statistics in Medicine, 10.1002/(SICI)1097-0258(19981030)17:20<2353::AID-SIM923>3.0.CO;2-Y, 17, 20, (2353-2369), (1998).
  • Approximate Bayesian inference for random effects meta‐analysis, Statistics in Medicine, 10.1002/(SICI)1097-0258(19980130)17:2<201::AID-SIM736>3.0.CO;2-9, 17, 2, (201-218), (1998).
  • BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META‐ANALYSIS, Statistics in Medicine, 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0, 15, 24, (2733-2749), (1998).
  • Cost-Effectiveness Analysis of Helicopter EMS for Trauma Patients, Annals of Emergency Medicine, 10.1016/S0196-0644(97)70010-6, 30, 4, (500-506), (1997).
  • Meta-analysis and prospective meta-analysis in childhood leukemia clinical research, Annals of Oncology, 10.1093/oxfordjournals.annonc.a010492, 7, 10, (1009-1014), (1996).
  • Bayesian meta-analysis, with application to studies of ETS and lung cancer, Lung Cancer, 10.1016/S0169-5002(96)90222-6, 14, (S171-S194), (1996).
  • Comment, Journal of the American Statistical Association, 10.1080/01621459.1996.10476924, 91, 434, (560-562), (1996).
  • Angiotensin converting enzyme inhibitors for heart failure, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002134, (1996).
  • Angiotensin converting enzyme inhibitors for heart failure, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002134.pub2, (1996).
  • Beta-blockers for myocardial infarction, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002129, (1996).
  • Meta-analysis: Statistical alchemy for the 21st century, Journal of Clinical Epidemiology, 10.1016/0895-4356(94)00110-C, 48, 1, (71-79), (1995).
  • “A statistician looks at met-analysis”: Discussion, Journal of Clinical Epidemiology, 10.1016/0895-4356(94)00100-5, 48, 1, (105-108), (1995).
  • Exploratory or analytic meta-analysis: Should we distinguish between them?, Journal of Clinical Epidemiology, 10.1016/0895-4356(94)00084-4, 48, 1, (109-116), (1995).
  • Radon and Lung Cancer Mortality: An Example of a Bayesian Ecological Analysis, Statistical Modelling, 10.1007/978-1-4612-0789-4_17, (133-140), (1995).
  • See more

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.